| Literature DB >> 15849491 |
George Marakis1, Konstantinos Ballas, Savas Rafailidis, Michael Alatsakis, Kalliopi Patsiaoura, Athanassios Sakadamis.
Abstract
Somatostatin-producing endocrine tumors are rare neoplasms usually arising in the pancreas and duodenum and they account for less than 1% of all gastrointestinal endocrine tumors. Besides somatostatinoma syndrome, which is characterized by diabetes mellitus, steatorrhea and cholelithiasis, patients with somatostatin-producing endocrine tumors commonly complain of nonspecific symptoms such as vague abdominal pain, weight loss or changes in bowel habits. Tumor behavior cannot be predicted by histological features alone, and malignancy is determined by the presence of metastases. We report here a case of malignant pancreatic endocrine tumor producing somatostatin presented as relapsing cholangitis who was treated with Whipple pancreatoduodenectomy.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15849491 DOI: 10.1159/000085286
Source DB: PubMed Journal: Pancreatology ISSN: 1424-3903 Impact factor: 3.996